JNJ-26070109
UNII DS98E85PRT

Substance Identification & Data

This profile provides standardized clinical and technical data for Jnj-26070109, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DS98E85PRT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DS98E85PRT
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
JNJ-26070109
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C23H16BrF2N4O3S.Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
INBCDHQNPKIMPZ-BTQNPOSSSA-M
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1ccc2c(c1S([N-]c3c(ccc(c3)Br)C(=O)N[C@H](C)c4c(cc(cc4)F)F)(=O)=O)nccn2.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Jnj-26070109. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(R)-4-BROMO-N-(1-(2,4-DIFLUOROPHENYL)ETHYL)-2-(((QUINOXALIN-5-YL)SULFONYL)AMINO)BENZAMIDE SODIUM SALT
SODIUM;(5-BROMO-2-(((1R)-1-(2,4-DIFLUOROPHENYL)ETHYL)CARBAMOYL)PHENYL)-QUINOXALIN-5-YLSULFONYLAZANIDE

Technical Codes

JNJ-26070109